2784 logo

Alfresa Holdings Corporation Stock Price

TSE:2784 Community·JP¥397.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

2784 Share Price Performance

JP¥2,172.00
-65.00 (-2.91%)
JP¥2,172.00
-65.00 (-2.91%)
Price JP¥2,172.00

2784 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet average dividend payer.

1 Risk
2 Rewards

Alfresa Holdings Corporation Key Details

JP¥3.0t

Revenue

JP¥2.8t

Cost of Revenue

JP¥215.3b

Gross Profit

JP¥187.4b

Other Expenses

JP¥28.0b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 06, 2025
153.72
7.19%
0.93%
6.4%
View Full Analysis

About 2784

Founded
2003
Employees
12452
CEO
Ryuji Arakawa
WebsiteView website
www.alfresa.com

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.

Recent 2784 News & Updates

Does Alfresa Holdings (TSE:2784) Have A Healthy Balance Sheet?

Oct 01
Does Alfresa Holdings (TSE:2784) Have A Healthy Balance Sheet?

Recent updates

No updates